| April 3, 2012 • Volume 9 / Number 7 |
The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.
- Featured Article: Targeted Drug Shows Promise in Common Form of Lymphoma »
- Drawbacks of Adding MRI to Mammography Plus Ultrasound May Outweigh Benefits »
- Ultrasound-Guided Breast-Conserving Surgery May Reduce Need for Further Surgeries »
- Anal HPV Infections and Precancerous Lesions Are Common in Men Who Have Sex with Men »
- Olaparib Delays Progression of Ovarian Cancer after Initial Treatment »
- Transplant Recipients at Higher Risk of Aggressive Form of Lymphoma »
- Some Melanoma Cells May Use the Body's Immune Response to Escape Destruction »
- Also in the Journals: Methylation Levels in HPV DNA May Indicate Risk for Cervical Precancer »
- A Conversation with Dr. Bert Vogelstein about Whole-Genome Sequencing to Predict
Cancer Risk »
- U.S. Cancer Deaths Continue Steady Decline »
- Drugs Target Epigenetic Changes to Reprogram Cancer Cells »
- Featured Clinical Trial: Virus Therapy for Extensive-Stage Small Cell Lung Cancer »
- Legislative Update »
- FDA Update »
- Notes »
Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov. |